Single Peptides · Exact presentation
Adamax · 10 mg Vial
Adamax · 10 mg Vial is an exact single peptide or compound entry. This strength is kept separate because concentration and calculations depend on vial amount.
Educational research information for this exact variation. It is not medical advice, a prescription, or proof of regulatory approval.
Separate commercial record
Availability in the Dominican Republic
This educational entry is separate from the live catalog. Check the exact commercial record for current availability, price, and lot documentation. View exact commercial record.
Dosing & Reconstitution Guide
For a 10 mg presentation, the reference concentration of 3.33 mg/mL mathematically corresponds to 3.003 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 3.33 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.0333 mg at this concentration.
Standard / Gradual Approach (3 mL = ~3.33 mg/mL)
The source chart summarizes “300 mcg–1 mg” at “Daily” frequency as educational information. PeptidosRD does not convert it into a clinical recommendation; any protocol must be checked against primary studies, applicable labeling, and qualified oversight.
Standard / Gradual Approach (3 mL = ~3.33 mg/mL)
| Week | Daily Dose | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 300 µg (0.3 mg) | 9 units (0.09 mL) |
| Weeks 3–4 | 500 µg (0.5 mg) | 15 units (0.15 mL) |
| Weeks 5–6 | 750 µg (0.75 mg) | 23 units (0.23 mL) |
| Weeks 7–8 | 1000 µg (1.0 mg) | 30 units (0.30 mL) |
Reconstitution Steps
For a 10 mg presentation, the reference concentration of 3.33 mg/mL mathematically corresponds to 3.003 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 3.33 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.0333 mg at this concentration.
Storage Instructions
Proper storage preserves peptide quality.
Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; stable for 1+ year.[5]
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 3–4 weeks and avoid freeze–thaw.[6]
Allow vials to reach room temperature before opening to reduce condensation uptake.
How This Works
It is studied for possible effects on neuronal signaling, neurotrophins, cellular stress, or neuroendocrine regulation. Proposed mechanisms vary widely across compounds.
Potential Benefits & Side Effects
Nervous-system effects can be difficult to predict, and long-term safety evidence is often insufficient.
Potential Benefits
The evidence base may include regional studies, small trials, or preclinical models. Clinical generalization requires caution and verifiable primary sources.
Source trail
Scientific references and source discovery
- PeptideDosages — exact Adamax · 10 mg Vial entrysecondary-structure
- PubMed — literature search for Adamaxprimary-discovery
- ClinicalTrials.gov — study search for Adamaxtrial-registry
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference